mhurhangee/ep-ind-claims huggingface dataset:
Headrest for a motor vehicle seat, said headrest comprising: - a fixed support portion intended to be associated with the top of the backrest of said seat, - a movable headrest portion associated, by means of a connecting device, with said fixed portion, said device being arranged in order to allow at least a vertical and longitudinal displacement of said movable portion in order to be able to arrange it in a plurality of adjustment positions, - a locking mechanism for locking said movable portion in the chosen adjustment position, - a locking surface rigidly connected to one of said portions and a locking member rigidly connected to the other of said portions, said member being movable between an unlocked configuration, in which it is at a distance from said surface, and a locked configuration, in which it engages with said surface in a plurality of vertical and longitudinal positions on said surface, in such a way as to allow said movable portion to be locked in the chosen adjustment position, - an unlocking device arranged to move said member away from said surface, in order to allow the adjustment of said movable portion to be modified, characterised in that the member and the surface are provided with a cross-over network of respective abutments arranged so as to engage with each other in the locked configuration and in that the abutments are pyramid-shaped inclined at the square base, so as to have four bearing sides (25, 26), so as to achieve bidirectional vertical and longitudinal locking. - a fixed support portion intended to be associated with the top of the backrest of said seat, - a movable headrest portion associated, by means of a connecting device, with said fixed portion, said device being arranged in order to allow at least a vertical and longitudinal displacement of said movable portion in order to be able to arrange it in a plurality of adjustment positions, - a locking mechanism for locking said movable portion in the chosen adjustment position, - a locking surface rigidly connected to one of said portions and a locking member rigidly connected to the other of said portions, said member being movable between an unlocked configuration, in which it is at a distance from said surface, and a locked configuration, in which it engages with said surface in a plurality of vertical and longitudinal positions on said surface, in such a way as to allow said movable portion to be locked in the chosen adjustment position, - an unlocking device arranged to move said member away from said surface, in order to allow the adjustment of said movable portion to be modified, characterised in that the member and the surface are provided with a cross-over network of respective abutments arranged so as to engage with each other in the locked configuration and in that the abutments are pyramid-shaped inclined at the square base, so as to have four bearing sides (25, 26), so as to achieve bidirectional vertical and longitudinal locking.
Kitchenware item comprising: - a pot suitable for receiving food and comprising a substrate which has a bottom and a side wall rising at the periphery of the bottom, and a heating electrical resistance arranged in the region of the side wall of the pot, - a source for the production of electricity connected to the electrical resistance in order to electrically supply it, characterised in that the substrate is metal and the electrical resistance is arranged: - either at the exterior of the substrate, - or embedded in said substrate, within: * either a moulded electroconductive metal material (3a1), * or several electroconductive metal layers (3a1, 3a2, 3a3, 3a4, 3a5) that are interconnected, without adhesive, by deformation and/or physicochemical metal connection, and in that the bottom, which has a lower surface to be placed facing an external heating source comprising one from: an electric plate, a flame coming from a source of gas, an induction coil (69, 71) for heating via induction of the pot, is adapted to resist the heat of said external heating source and comprises for this: - a multilayer substrate structure, with different metals or metal alloys (3a1, 3a2, 3a3, 3a4, 3a5), - and/or at least: * a stiffening imprint (17, 170), * or an insert made of a metal that can be magnetised which is fixed to a malleable metal layer of the substrate and/or which is harder than this malleable layer. - a pot suitable for receiving food and comprising a substrate which has a bottom and a side wall rising at the periphery of the bottom, and a heating electrical resistance arranged in the region of the side wall of the pot, - a source for the production of electricity connected to the electrical resistance in order to electrically supply it, - either at the exterior of the substrate, - or embedded in said substrate, within: * either a moulded electroconductive metal material (3a1), * or several electroconductive metal layers (3a1, 3a2, 3a3, 3a4, 3a5) that are interconnected, without adhesive, by deformation and/or physicochemical metal connection, * either a moulded electroconductive metal material (3a1), * or several electroconductive metal layers (3a1, 3a2, 3a3, 3a4, 3a5) that are interconnected, without adhesive, by deformation and/or physicochemical metal connection, - a multilayer substrate structure, with different metals or metal alloys (3a1, 3a2, 3a3, 3a4, 3a5), - and/or at least: * a stiffening imprint (17, 170), * or an insert made of a metal that can be magnetised which is fixed to a malleable metal layer of the substrate and/or which is harder than this malleable layer. * a stiffening imprint (17, 170), * or an insert made of a metal that can be magnetised which is fixed to a malleable metal layer of the substrate and/or which is harder than this malleable layer.
Method for the fault management of a fault on a DC voltage side of a converter assembly having a modular multi-stage converter which incorporates switching modules (SM1, SM2), each of which comprises a plurality of semiconductor switches (H1-4, S1-2) and at least one energy store, wherein a number of the switching modules are switching modules of a first type, and a number of other switching modules are switching modules of a second type, wherein, in the operation of the converter assembly, a positive switching module voltage, a negative switching module voltage or a zero voltage are respectively generated at terminals (X1, X2) of the switching modules of the first type, and a positive switching module voltage or a zero voltage are respectively generated at terminals (X1, X2) of the switching modules of the second type, wherein - the DC voltage side fault is detected, - the switching modules of the first type are actuated such that the polarity of their energy store voltages corresponds to the polarity of a fault current, and - the energy stores of the switching modules of the first type are charged to a voltage in excess of their rated voltage by a factor of 1.1 to 1.5. - the DC voltage side fault is detected, - the switching modules of the first type are actuated such that the polarity of their energy store voltages corresponds to the polarity of a fault current, and - the energy stores of the switching modules of the first type are charged to a voltage in excess of their rated voltage by a factor of 1.1 to 1.5.
A compound represented by a formula: [wherein, W 1 represents an oxygen atom, W 2 represents a methyl group, R 15 represents a halogen atom, a methyl group, a cyclopropyl group or a methoxy group, u is 0, E represents #-C(Z 1)=N-N=C(Z 3)-O-CH 2 -, G and Z 1 together with carbon atoms to which they are bound form an indan-1-ylidene group, a 1,2,3,4-tetrahydronaphthalen-1-ylidene group, a 2,3-dihydrobenzofuran-3-ylidene group, a 3,4-dihydro-2H-1-benzopyran-4-ylidene group {the indan-1-ylidene group, the 1,2,3,4-tetrahydronaphthalen-1-ylidene group, the 2,3-dihydrobenzofuran-3-ylidene group, and the 3,4-dihydro-2H-1-benzopyran-4-ylidene group may have one or more substituents selected from the group consisting of a halogen atom, a C1-C3 alkyl group which may have one or more halogen atoms, and a C1-C3 alkoxy group which may have one or more halogen atoms}, or a 3,4-dihydro-2H-1-benzothiopyran-4-ylidene group {the 3,4-dihydro-2H-1-benzothiopyran-4-ylidene group may have one or more substituents selected from the group consisting of an oxo group, a halogen atom, a C1-C3 alkyl group which may have one or more halogen atoms, and a C1-C3 alkoxy group which may have one or more halogen atoms}, # represents a binding site to G, Z 3 represents an ethyl group]. W 1 represents an oxygen atom, W 2 represents a methyl group, R 15 represents a halogen atom, a methyl group, a cyclopropyl group or a methoxy group, u is 0, E represents #-C(Z 1)=N-N=C(Z 3)-O-CH 2 -, G and Z 1 together with carbon atoms to which they are bound form an indan-1-ylidene group, a 1,2,3,4-tetrahydronaphthalen-1-ylidene group, a 2,3-dihydrobenzofuran-3-ylidene group, a 3,4-dihydro-2H-1-benzopyran-4-ylidene group {the indan-1-ylidene group, the 1,2,3,4-tetrahydronaphthalen-1-ylidene group, the 2,3-dihydrobenzofuran-3-ylidene group, and the 3,4-dihydro-2H-1-benzopyran-4-ylidene group may have one or more substituents selected from the group consisting of a halogen atom, a C1-C3 alkyl group which may have one or more halogen atoms, and a C1-C3 alkoxy group which may have one or more halogen atoms}, or a 3,4-dihydro-2H-1-benzothiopyran-4-ylidene group {the 3,4-dihydro-2H-1-benzothiopyran-4-ylidene group may have one or more substituents selected from the group consisting of an oxo group, a halogen atom, a C1-C3 alkyl group which may have one or more halogen atoms, and a C1-C3 alkoxy group which may have one or more halogen atoms}, # represents a binding site to G, Z 3 represents an ethyl group].
Flat carpet comprising a carpet fabric with a visible side and a back side, as well as a back layer, smaller in width and length than the carpet fabric, provided on the back side of said carpet fabric, wherein one or more edges (21a, 21b, 21c, 21d) of said carpet fabric are folded back, wherein said folded back edges (22a, 22b, 22c, 22d) thus obtained are fixed to said back layer by means of an adhesive tape (5a, 5b, 5c, 5d), characterised in that said folded edges (22a, 22b, 22c, 22d) are folded back to an edge of said back layer, wherein said adhesive tape (5a, 5b, 5c, 5d) is partially provided on said back layer and partially arranged on said folded edge (22a, 22b, 22c, 22d) of said carpet fabric.
A microfluidic method for manufacturing an emulsion comprising drops in emulsion in an external solution, the drops containing a fluid, in which method: - the fluid is being circulated along a first main channel, - a portion of the fluid circulating in the first main channel is withdrawn, via a plurality of microchannels positioned along the first main channel, which each communicate individually with said first main channel and each emerge individually in a space filled with external solution, the first main channel being maintained at a greater pressure than said space filled with external solution, the first main channel having a passage cross-section at least 5 times greater than each microchannel, - the drops are formed when the fluid passes from each microchannel into said space filled with external solution, the method being characterized in that the fluid is being circulated along the first main channel between a first tank and a second tank which are maintained under excess pressure respectively at a first pressure and at a second pressure different from the first pressure, the first and second pressures being greater than atmospheric pressure, and the fluid is being circulated alternately in opposite directions along the first main channel, the first and second pressures being varied so that the first pressure is alternately greater and lower than the second pressure. - the fluid is being circulated along a first main channel, - a portion of the fluid circulating in the first main channel is withdrawn, via a plurality of microchannels positioned along the first main channel, which each communicate individually with said first main channel and each emerge individually in a space filled with external solution, the first main channel being maintained at a greater pressure than said space filled with external solution, the first main channel having a passage cross-section at least 5 times greater than each microchannel, - the drops are formed when the fluid passes from each microchannel into said space filled with external solution,
A system including an apparatus, the apparatus comprising: an implantable housing; a heart signal sensing circuit configured to sense intrinsic electrical heart signals; a ventricular tachyarrhythmia detector circuit, operatively coupled to the heart signal sensing circuit, the detector circuit operable to detect a VT based on the sensed heart signals; a processor configured to control delivery of an anti-tachyarrhythmia pacing therapy based on the detected VT; and an energy delivery circuit configured to deliver the ATP therapy in response to the detected VT, wherein the apparatus does not include a shock circuit capable of delivering a therapeutically-effective cardioverting or defibrillating shock, wherein the apparatus is programmable such that ATP therapy is only available for delivery if an additional implantable cardioverter/defibrillator device is present in the patient. an implantable housing; a heart signal sensing circuit configured to sense intrinsic electrical heart signals; a ventricular tachyarrhythmia detector circuit, operatively coupled to the heart signal sensing circuit, the detector circuit operable to detect a VT based on the sensed heart signals; a processor configured to control delivery of an anti-tachyarrhythmia pacing therapy based on the detected VT; and an energy delivery circuit configured to deliver the ATP therapy in response to the detected VT, wherein the apparatus does not include a shock circuit capable of delivering a therapeutically-effective cardioverting or defibrillating shock, wherein the apparatus is programmable such that ATP therapy is only available for delivery if an additional implantable cardioverter/defibrillator device is present in the patient.
A combustion device comprising burners to burn fuel with an amount of air of theoretical air or less and a furnace wall, the burners being disposed on the furnace wall, and after-air ports (7a,7b) to supply air, the after-air ports (7a,7b) being disposed on the furnace wall on the downstream side above from the position where the burners are disposed, the after-air ports (7a,7b) comprising: a primary after-air nozzle which is provided at the central part in an opening of the after-air port to supply a primary after-air; secondary after-air nozzles which are provided in the opening of the after-air port at the outside of the primary after-air nozzle to supply a secondary after-air; and one or more pairs of secondary after-air guide vanes which are provided in the outlet parts of the secondary after-air nozzles and have inclination angles with respect to a central axis of the after-air port, so as to deflect the secondary after-air right and left in the horizontal direction and supply the same, characterized in that the primary after-air nozzle has a larger vertical height than horizontal width. a primary after-air nozzle which is provided at the central part in an opening of the after-air port to supply a primary after-air; secondary after-air nozzles which are provided in the opening of the after-air port at the outside of the primary after-air nozzle to supply a secondary after-air; and one or more pairs of secondary after-air guide vanes which are provided in the outlet parts of the secondary after-air nozzles and have inclination angles with respect to a central axis of the after-air port, so as to deflect the secondary after-air right and left in the horizontal direction and supply the same, characterized in that the primary after-air nozzle has a larger vertical height than horizontal width.
Discharge station for a conveyor, particularly an overhead conveyor comprising conveying carriers which are movable along a conveying path in a conveying direction, for receiving to-be-conveyed goods, particularly mounting elements, preferably hooks, of the to-be-conveyed goods, wherein the discharge station comprises an actuator that cooperates with an engagement body including an engagement portion, wherein the engagement portion is adapted to a support body of the conveying carrier, wherein the engagement body is selectively movable between an engagement configuration and an out-of-engagement configuration, wherein the engagement portion is, in the out-of-engagement configuration, spaced from the support body, wherein the engagement portion, in the engagement configuration, approaches the support body which is movable along the conveying path, to selectively unload a passing to-be-conveyed good which is received at the support body from the conveying path, and wherein the engagement body comprises a guide contour, to feed the to-be-unloaded to-be-conveyed good to a discharge line, characterized in that the engagement portion, preferably laterally, at least partially huddles against the support body, and that the engagement portion can be fed basically laterally, preferably approximately in a transverse direction with respect to the conveying direction, to the support body.
An in vitro method for therapy follow-up in patients being suspected of having sepsis wherein the concentration of mature adrenomedullin (1-52-amide) and/or mature ADM 1-52-Gly in a sample of bodily fluid of said septic patient is determined using an assay comprising two binders that are selected from the group comprising an anti-adrenomedullin antibody and an anti-ADM antibody fragment binding to ADM and that bind to two different regions within the region of mature adrenomedullin (21-52-amide) and/ or adrenomedullin-Gly, that is amino acid 21-52-amide (SEQ ID No. 1) or amino acid 21-52-Gly (SEQ ID No. 2) respectively, wherein each of said regions comprises at least 4 or 5 amino acids.
A method of purifying a full-length target oligonucleotide from a pool further containing shorter or longer same-sequence oligonucleotide by-products, the method comprising: a) amplifying the pool to form a second pool of oligonucleotides; b) transcribing the second pool of oligonucleotides to form an RNA pool wherein the RNA molecules contain codons for at least one tag sequence; c) ligating the molecules of the RNA pool to puromycin; d) translating the puromycin-ligated RNA molecules to form a pool of chimeric molecules containing the RNA linked to a peptide expressed from the RNA; e) capturing and isolating the chimeric molecules that express the tag; f) reverse transcribing the RNA of the isolated chimeric moieties to form a pool of cDNA comprising the purified full-length oligonucleotide. a) amplifying the pool to form a second pool of oligonucleotides; b) transcribing the second pool of oligonucleotides to form an RNA pool wherein the RNA molecules contain codons for at least one tag sequence; c) ligating the molecules of the RNA pool to puromycin; d) translating the puromycin-ligated RNA molecules to form a pool of chimeric molecules containing the RNA linked to a peptide expressed from the RNA; e) capturing and isolating the chimeric molecules that express the tag; f) reverse transcribing the RNA of the isolated chimeric moieties to form a pool of cDNA comprising the purified full-length oligonucleotide.
A swingarm support structure configured to support, on a vehicle body frame, a swingarm that supports a rear wheel, the swingarm support structure comprising: a pair of left and right vertical frame pieces constituting a part of the vehicle body frame and extending in a vertical direction; a pair of left and right swingarm brackets (9L, 9R) fixed to the pair of left and right vertical frame pieces, respectively; wherein each of the pair of left and right swingarm brackets (9L, 9R) includes left and right opposing portions (320, 340) disposed so as to be spaced apart in the vehicle widthwise direction, and the pivot is supported by each of the left and right opposing portions (320, 340) at each of the swingarm brackets (9L, 9R); characterised in that the pivot is supported by the swingarm brackets (9L, 9R) and configured to swingably support the swingarm outward in a vehicle widthwise direction of the swingarm brackets (9L, 9R), and in that a power transmission mechanism configured to transmit power from a drive source of a motorcycle to the rear wheel is disposed outward of the swingarm bracket (9L, 9R) in the vehicle widthwise direction, and a rigidity of one swingarm bracket of the pair of left and right swingarm brackets (9L, 9R) is set to be higher than a rigidity of the other swingarm bracket, the one swingarm bracket being located on a side on which the power transmission mechanism is disposed. a pair of left and right vertical frame pieces constituting a part of the vehicle body frame and extending in a vertical direction; a pair of left and right swingarm brackets (9L, 9R) fixed to the pair of left and right vertical frame pieces, respectively; wherein each of the pair of left and right swingarm brackets (9L, 9R) includes left and right opposing portions (320, 340) disposed so as to be spaced apart in the vehicle widthwise direction, and the pivot is supported by each of the left and right opposing portions (320, 340) at each of the swingarm brackets (9L, 9R); characterised in that the pivot is supported by the swingarm brackets (9L, 9R) and configured to swingably support the swingarm outward in a vehicle widthwise direction of the swingarm brackets (9L, 9R), and in that a power transmission mechanism configured to transmit power from a drive source of a motorcycle to the rear wheel is disposed outward of the swingarm bracket (9L, 9R) in the vehicle widthwise direction, and a rigidity of one swingarm bracket of the pair of left and right swingarm brackets (9L, 9R) is set to be higher than a rigidity of the other swingarm bracket, the one swingarm bracket being located on a side on which the power transmission mechanism is disposed.
A pharmaceutical composition in the form of an aqueous suspension comprising: a. temozolomide or a salt thereof; b. at least one agent controlling the solid state of temozolomide in suspension; c. water; d. optionally at least one acid in a quantity so that the pH of the composition is below 5, wherein the concentration of temozolomide is higher than 10 mg/ml; and the agent controlling the solid state of temozolomide in suspension is a compound selected from the group consisting of: silica, colloidal silica, hydrophobic colloidal silica, fumed silica, mesoporous silica, magnesium aluminium silicate, bentonite, saponite and kaolin. a. temozolomide or a salt thereof; b. at least one agent controlling the solid state of temozolomide in suspension; c. water; d. optionally at least one acid in a quantity so that the pH of the composition is below 5, wherein the concentration of temozolomide is higher than 10 mg/ml; and the agent controlling the solid state of temozolomide in suspension is a compound selected from the group consisting of: silica, colloidal silica, hydrophobic colloidal silica, fumed silica, mesoporous silica, magnesium aluminium silicate, bentonite, saponite and kaolin.
A pressurized metered dose inhaler for dispensing an aerosol formulation comprising particles of a medicament suspended in liquefied propellant, optionally in combination with one or more excipients, the inhaler comprising an aerosol container equipped with a metered dose valve, where a formulation chamber is defined in part by the internal walls of the container, and wherein the inhaler further comprises a porous, fluid permeable, particulate semi-permeable body located within the formulation chamber adjacent to the metered dose valve, characterized in that the porous body comprises a material having a nominal pore size of from 125 micrometers to 2000 micrometers.